Outcomes research examining treatments, quality of life and costs in HER2-negative and triple-negative metastatic breast cancer: a systematic literature review
出版年份 2018 全文链接
标题
Outcomes research examining treatments, quality of life and costs in HER2-negative and triple-negative metastatic breast cancer: a systematic literature review
作者
关键词
-
出版物
Journal of Comparative Effectiveness Research
Volume 7, Issue 1, Pages 67-83
出版商
Future Medicine Ltd
发表日期
2018-01-05
DOI
10.2217/cer-2017-0027
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Untapped Potential of Observational Research to Inform Clinical Decision Making: American Society of Clinical Oncology Research Statement
- (2017) Kala Visvanathan et al. JOURNAL OF CLINICAL ONCOLOGY
- Real-world analysis of eribulin in metastatic breast cancer (MBC): An assessment of time to treatment failure (TTF) in a community oncology setting.
- (2017) George Dranitsaris et al. JOURNAL OF CLINICAL ONCOLOGY
- Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy
- (2017) Davinia S.E. Seah et al. Journal of the National Comprehensive Cancer Network
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Time on treatment of everolimus and chemotherapy among postmenopausal women with hormone-receptor-positive/human-epidermal-growth-factor-receptor-2-negative metastatic breast cancer: a retrospective claims study in the US
- (2016) Nanxin Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Revisiting the Surveillance Epidemiology and End Results Cancer Registry and Medicare Health Outcomes Survey (SEER-MHOS) Linked Data Resource for Patient-Reported Outcomes Research in Older Adults with Cancer
- (2016) Erin E. Kent et al. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
- Racial differences in outcomes for patients with metastatic breast cancer by disease subtype
- (2015) Ines Vaz-Luis et al. BREAST CANCER RESEARCH AND TREATMENT
- Survival of patients with de-novo metastatic breast cancer: analysis of data from a large breast cancer-specific private practice, a university-based cancer center and review of the literature
- (2015) Simon B. Zeichner et al. BREAST CANCER RESEARCH AND TREATMENT
- Comparative Effectiveness Analysis of Monotherapy With Cytotoxic Agents in Triple-negative Metastatic Breast Cancer in a Community Setting
- (2015) George Dranitsaris et al. CLINICAL THERAPEUTICS
- Everolimus use and associated factors among post-menopausal women with hormonal receptor positive/human epidermal growth factor receptor 2 negative metastatic breast cancer
- (2015) Nanxin Li et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2− metastatic breast cancer: a retrospective chart review in community oncology practices in the US
- (2015) Jipan Xie et al. CURRENT MEDICAL RESEARCH AND OPINION
- Real-world effectiveness of everolimus-based therapy versus endocrine monotherapy and chemotherapy in patients of HR+/HER2- breast cancer with liver metastasis in the USA
- (2015) Peggy L Lin et al. EXPERT OPINION ON PHARMACOTHERAPY
- Physician experiences and preferences in the treatment of HR+/HER2− metastatic breast cancer in the United States: a physician survey
- (2015) Peggy L. Lin et al. Cancer Medicine
- Cost-effectiveness analysis of everolimus plus exemestane versus exemestane alone for treatment of hormone receptor positive metastatic breast cancer
- (2014) Vakaramoko Diaby et al. BREAST CANCER RESEARCH AND TREATMENT
- Abstract P1-14-03: Chemotherapy and endocrine therapy treatment patterns among patients with hormone receptor positive (HR+)/HER2 negative advanced breast cancer
- (2014) Y Hao et al. CANCER RESEARCH
- Abstract P3-06-09: Survival among patients with hormone receptor positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) advanced breast cancer: A real-world observational study
- (2014) NM Engel-Nitz et al. CANCER RESEARCH
- Treatment patterns and duration in post-menopausal women with HR+/HER2− metastatic breast cancer in the US: a retrospective chart review in community oncology practices (2004–2010)
- (2014) Alexander R. Macalalad et al. CURRENT MEDICAL RESEARCH AND OPINION
- Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2−) breast cancer patients in the United States: 2002–2012
- (2014) Elyse Swallow et al. CURRENT MEDICAL RESEARCH AND OPINION
- Chemotherapy and Targeted Therapy for Women With Human Epidermal Growth Factor Receptor 2–Negative (or unknown) Advanced Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2014) Ann H. Partridge et al. JOURNAL OF CLINICAL ONCOLOGY
- Can Patient Navigation Improve Receipt of Recommended Breast Cancer Care? Evidence From the National Patient Navigation Research Program
- (2014) Naomi Y. Ko et al. JOURNAL OF CLINICAL ONCOLOGY
- The association of chemotherapy versus hormonal therapy and health outcomes among patients with hormone receptor-positive, HER2−negative metastatic breast cancer: experience from the patient perspective
- (2014) Shaloo Gupta et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Markov Model and Cost-Effectiveness Analysis of Bevacizumab in HER2-Negative Metastatic Breast Cancer
- (2013) Tamer Refaat et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Breast cancer as a systemic disease: a view of metastasis
- (2013) A. J. Redig et al. JOURNAL OF INTERNAL MEDICINE
- Limited Overall Survival in Patients with Brain Metastases from Triple Negative Breast Cancer
- (2012) Patrick G. Morris et al. Breast Journal
- Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network
- (2012) Nancy U. Lin et al. CANCER
- Budget impact analysis of everolimus for the treatment of hormone receptor positive, human epidermal growth factor receptor-2 negative (HER2-) advanced breast cancer in the United States
- (2012) Jipan Xie et al. JOURNAL OF MEDICAL ECONOMICS
- Economic Burden of Cancer in the United States: Estimates, Projections, and Future Research
- (2011) K. R. Yabroff et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Retrospective study of the effect of disease progression on patient reported outcomes in HER-2 negative metastatic breast cancer patients
- (2011) Mark S Walker et al. Health and Quality of Life Outcomes
- Quality of Life and Experience of Care in Women With Metastatic Breast Cancer: A Cross-Sectional Survey
- (2011) Elizabeth Reed et al. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT
- Projections of the Cost of Cancer Care in the United States: 2010-2020
- (2011) A. B. Mariotto et al. JNCI-Journal of the National Cancer Institute
- Cisplatin–gemcitabine therapy in metastatic breast cancer: Improved outcome in triple negative breast cancer patients compared to non-triple negative patients
- (2010) Nebu Koshy et al. BREAST
- Prognosis of Women With Metastatic Breast Cancer byHER2Status and Trastuzumab Treatment: An Institutional-Based Review
- (2009) Shaheenah Dawood et al. JOURNAL OF CLINICAL ONCOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now